Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,246 public trials 1,181 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Completed

Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)

NCT00097214

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • ImClone Investigational Site Bentonville, Arkansas, United States
  • ImClone Investigational Site Tucker, Georgia, United States
  • ImClone Investigational Site Evanston, Illinois, United States
  • ImClone Investigational Site Louisville, Kentucky, United States
View Trial Details
Completed

An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer

NCT00054899

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +12 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • Cancer Centers of Florida Orlando, Florida, United States
  • New York Oncology Hematology Albany, New York, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

Phase 1 Study of TG01 and Erlotinib in Non-small Cell Lung Cancer (NCSLC) Patients

NCT00569114

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • City of Hope Duarte, California, United States
  • University of Southern California Los Angeles, California, United States
  • University of California at Davis Sacramento, California, United States
View Trial Details
Completed

Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer

NCT00143455

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations
  • Pfizer Investigational Site Wels, Austria
  • Pfizer Investigational Site Ghent, Belgium
  • Pfizer Investigational Site Leuven, Belgium
  • Pfizer Investigational Site Liège, Belgium
View all 67 locations
View Trial Details
Completed

Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC)

NCT00191139

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Denver, Colorado, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph South Bend, Indiana, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Baltimore, Maryland, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Kalamazoo, Michigan, United States
View all 15 locations
View Trial Details

Related conditions